Meningoencephalitis associated with human parvovirus B19

Clinical Microbiology and Infection

Volumn 14, Issue 12, 2008, Pages 1188-1190

  Coskun, O ^a   Erdem, H ^a   Gul, H C ^a   Besirbellioglu, B A ^a   Sener, K ^b   Eyigun, C P ^a  

^a Department of Infectious Diseases and Clinical Microbiology ^*  (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CEFTRIAXONE; GLUCOSE; PROTEIN;

AGED; AGITATION; BLOOD CELL COUNT; BRAIN ATROPHY; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; COGNITIVE DEFECT; CONFUSION; DYSARTHRIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; GLIOSIS; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; LETTER; MENINGOENCEPHALITIS; MENTAL DISEASE; MUSCLE ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARVOVIRUS; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT;

PARVOVIRUS;

EID: 57649222388     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02110.x     Document Type: Letter

References (12)

1. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15: 485-505.
2. Barah F, Vallely PJ, Cleator GM, Kerr JR. Neurological manifestations of human parvovirus B19 infection. Rev Med Virol 2003; 13: 185-199.
3. Cassinotti P, Schultze D, Schlageter P, Chevili S, Siegl G. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 1993; 12: 701-704.
4. Koduri PR, Naides SJ. Aseptic meningitis caused by parvovirus B19. Clin Infect Dis 1995; 21: 1053.
5. Tabak F, Mert A, Ozturk R, Koksal V, Akbas I, Aktuglu Y. Prolonged fever caused by parvovirus B19-induced meningitis: Case report and review. Clin Infect Dis 1999; 29: 446-447.
6. Druschky K, Walloch J, Heckmann J, Schmidt B, Stefan H, Neundorfer B. Chronic parvovirus B-19 meningoencephalitis with additional detection of Epstein-Barr virus DNA in the cerebrospinal fluid of an immunocompetent patient. J Neurovirol 2000; 6: 418-422.
7. Heegaard ED, Peterlund NA, Hornsleth A. Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma. Scand J Infect Dis 1995; 27: 631-633.
8. Haseyama K, Kudoh T, Yoto Y, Suzuki N, Chiba S. Detection of human parvovirus B19 DNA in cerebrospinal fluid. Pediatr Infect Dis J 1997; 16: 324-326.
9. Barah F, Vallely PJ, Chiswick ML, Cleator GM, Kerr JR. Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 2001; 358: 729-730.
10. Griffin DE. Encephalitis, myelitis and neuritis. In: Mandell GL, Bennet JE, Dolin R, eds. Mandell, Bennett, & Dolin: Principles and practice of infectious diseases, 6th edn. New York: Churchill Livingstone, 2005; 1144-1150.
11. Saag KG, True CA, Naides SJ. Intravenous immunoglobulin treatment of chronic parvovirus B19 arthropathy. Arthritis Rheum 1993; 36 (suppl): S67.
12. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321: 519-523.